|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||18.30 - 20.00|
|52 Week Range||8.38 - 20.00|
|PE Ratio (TTM)||-9.04|
|Earnings Date||Nov 1, 2017 - Nov 6, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||23.78|
Epizyme (EPZM) was a big mover last session, as the company saw its shares rise nearly 8% on the day amid huge volumes.
CAMBRIDGE, Mass., Sept. 19, 2017-- Epizyme, Inc., a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced the closing of its public offering of 10,557,000 shares ...
These stocks helped lead the market higher. Find out why.